newsfilter
← Latest News
Business Wire·

Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update

Revenue of $164.9 million, compared to $157.2 million in first quarter 2025 Increase in 2026 revenue guidance to $950 – $1,050 million Net loss of $31.8 million, compared to net income of $20.5 million in first